AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Liminatus Pharma, Inc. Class A Common Stock
$2.82
-$29.22 (-91.20%)
Previous Close
$2.90
Day Range
$2.75$3.00
Year Range
$2.75$141.50
Market Cap
3.79M
AVG Volume
487.25K
Trailing/Forward PE
-0.12/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQ
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: LIMN
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.
Video analysis: LIMN
All videosNo video analysis for this stock yet. Request one from our team.
News: LIMN
Similar companies
-
Alterity Therapeutics Limited
ATHE
·
NASDAQ
Compare
-
NanoViricides, Inc.
NNVC
·
New York Stock Exchange Arca
Compare
-
Evaxion Biotech A/S
EVAX
·
NASDAQ
Compare
-
Jasper Therapeutics, Inc.
JSPR
·
NASDAQ
Compare
-
Dyadic International, Inc.
DYAI
·
NASDAQ
Compare
-
SAB Biotherapeutics, Inc.
SABS
·
NASDAQ
Compare